NXERA PHARMA CO., LTD. · ネクセラファーマ株式会社
Ownership & governance
Executives 5Directors 7Avg age 52Avg tenure 3.3y
CC
Chris Cargill
Chief Executive Officer
Age 42Since 2022-03-23Profile →
+11
Executives5
Board of directors7
CC
Chris Cargill→
Director/Board Member
Age 42Since 2022-03-23
DR
David Roblin
Director/Board Member
Age 59Since 2018-06-21
RS
Rolf Soderstrom
Director/Board Member
Age 61Since 2020-03-24
ET
Eiko Tomita
Director/Board Member
Age 65Since 2023-03-31
NS
Naoko Shimura
Director/Board Member
Age 52Since 2025-03-25
NR
Nicola Rabson
Director/Board Member
—Since 2025-03-25
TM
Takeo Morooka
Director/Board Member
—Since 2026-03-24
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Daisuke Gomi | 11.42 % | 10,563,000 |
| JIC Venture Growth Investments Co. Ltd. | 6.067 % | 5,610,000 |
| Taiyo Pacific Partners LP | 4.699 % | 4,345,100 |
| PFIZER INC. | 2.039 % | 1,885,136 |
| Arcus Investment Ltd. | 1.854 % | 1,714,300 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Chris Cargill | Chief Executive Officer | 2022-03-23 | - |
| Hironoshin Nomura | Director of Finance/CFO | 2022-03-23 | - |
| Makoto Sugita | Chief Tech/Sci/R&D Officer | 2024-09-30 | - |
| Matt Barnes | Chief Tech/Sci/R&D Officer | — | - |
| Toshihiro Maeda | Chief Operating Officer | 2023-11-30 | - |
| クリストファー・カーギル | 取締役取締役会会長 | 2018-11-01 | - |
| デビッド・ロブリン | 取締役 | 2018-06-01 | - |
| ニコラ・ラブソン | 取締役 | 2025-03-01 | - |
Registry · as of 2026-12-31
Group companies
| Name | Category |
|---|---|
| Nxera Pharma UK Ltd. | Pharmaceuticals: Major |
| Nxera Pharma UK Ltd. | Pharmaceuticals: Major |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 2,015Range 1,000–4,500Analysts 8
1,000Mean 2,0154,500
- Strong buy 1
- Buy 5
- Hold 2
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.